Kardiochirurgia i Torakochirurgia Polska

Abstract

1/2020 vol. 17
Review paper

Stem cells and new intervention measures as emerging therapy in cardiac surgery

  1. Cardiac Surgery Unit, Tor Vergata University Hospital, Rome, Italy
  2. Department of Pathobiology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy
Kardiochir Torakochir Pol 2020; 17 (1): 1-7
Online publish date: 2020/04/09
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Cardiovascular disease (CVD) presents a great burden for elderly patients, their caregivers, and health systems. Structural and functional alterations of vessels accumulate throughout life, culminating in increased risk of developing CVD. Several inflammatory pathway are involved in vascular ageing. The growing elderly population worldwide highlights the need to understand how aging promotes CVD in order to develop new strategies to confront this challenge. In this review we analyzed the role of stem cells and new intervention measures as emerging drugs for vascular aging.
Share
without publication fees
without publication fees